MMA
REGN icon

Miracle Mile Advisors’s Regeneron Pharmaceuticals REGN Stock Holding History

Miracle Mile Advisors’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.96M Sell
4,749
-148
-3% -$101K 0.03% 272
2026
Q1 		$3.78M Buy
4,897
+1,155
+31% +$884K 0.05% 224
2025
Q4 		$2.89M Buy
3,742
+276
+8% +$187K 0.04% 254
2025
Q3 		$1.95M Buy
3,466
+280
+9% +$158K 0.03% 299
2025
Q2 		$1.67M Buy
3,186
+820
+35% +$458K 0.03% 272
2025
Q1 		$1.5M Buy
2,366
+962
+69% +$662K 0.03% 260
2024
Q4 		$1M Sell
1,404
-1,158
-45% -$972K 0.02% 338
2024
Q3 		$2.69M Buy
2,562
+286
+13% +$318K 0.06% 163
2024
Q2 		$2.39M Buy
2,276
+225
+11% +$218K 0.06% 171
2024
Q1 		$1.97M Buy
2,051
+554
+37% +$527K 0.05% 184
2023
Q4 		$1.31M Buy
1,497
+1,235
+471% +$1.02M 0.04% 215
2023
Q3 		$216K Sell
262
-24
-8% -$18.9K 0.01% 449
2023
Q2 		$206K Buy
286
+30
+12% +$23.1K 0.01% 477
2023
Q1 		$210K Buy
+256
New +$193K 0.01% 471
2020
Q3 		– Sell
-3,506
Closed -$2.19M – 393
2020
Q2 		$2.19M Buy
+3,506
New +$1.99M 0.18% 120

Other funds holding REGN

Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
GA
GuoLine Advisory Singapore $1.07B AUM 26.27% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
VF
Vest Financial Mclean, Virginia $9.52B AUM 31.6% 1-Year Est. Return
WCM
Wedge Capital Management Charlotte, North Carolina $6.06B AUM 47.24% 1-Year Est. Return
AIP
ARS Investment Partners New York $2.29B AUM 113.95% 1-Year Est. Return

Miracle Mile Advisors's REGN Position: Q2 2026 in Review

Miracle Mile Advisors reduced its Regeneron Pharmaceuticals (REGN) stake by 3% in Q2 2026, selling an estimated $101K and leaving 4,749 shares worth $2.96M. The position accounts for 0.03% of the portfolio, ranked #272.

Miracle Mile Advisors first reported a position in REGN in Q2 2020 and has held it in 15 quarters since. The position peaked at $3.78M in Q1 2026. 334 funds tracked by Wall St. Rank hold REGN as of Q2 2026.

  • Miracle Mile Advisors held 4,749 shares of Regeneron Pharmaceuticals worth $2.96M as of Q2 2026.
  • Miracle Mile Advisors sold 148 Regeneron Pharmaceuticals shares in Q2 2026, an estimated $101K.
  • Regeneron Pharmaceuticals made up 0.03% of Miracle Mile Advisors's portfolio in Q2 2026, its #272 holding.
  • Miracle Mile Advisors first reported a position in Regeneron Pharmaceuticals in Q2 2020 and has held it in 15 quarters since.
  • Miracle Mile Advisors's Regeneron Pharmaceuticals position peaked at $3.78M in Q1 2026.
  • 334 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.

Based on Miracle Mile Advisors's 13F filing for Q2 2026, filed 22 Jul 2026.